Backgrounds: Prefoldin, a molecular chaperone comprised of six subunits, prevents misfolding of newly synthesized nascent polypeptides. 
INTRODUCTION

Analyses of aggregate-containing cells and cell death
Neuroblastoma Neuro-2a cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% calf serum. Cells were cultured on a 3.5-cm glass bottom dish (Iwaki, Tokyo, Japan) coated with type IV collagen (Cellmatrix, Nitta Gelatin, Osaka, Japan).
Nucleotide sequences of the upper and lower strands for siRNA were as follows: Proteins were then reacted with an IRDye800-or Alexa Fluor 680-conjugated secondary antibody and visualized by using an infrared imaging system (Odyssey, LI-COR, Lincoln, NE, USA).
Anti-PFD2 and anti-PFD4 antibodies were established by injection of GST-PFD2 and GST-PFD4, respectively, into rabbits. The anti-PFD2 antibody was purified from rabbit serum, and serum from GST-PFD4-injected rabbits was used as the anti-PFD4 antibody. 
Glycerol density gradient centrifugation to separate the prefoldin complex
Immunofluorescence microscopy
Neuro-2a cells were cultured on coverslips and 
Filter-trap assay of cell lysates
FCS analysis
At 48 h after transfection, cells were lysed in PBS containing 1% Triton-X100 and protease inhibitors, sonicated as described above, and centrifuged at 15,000 rpm for 10 min at 4°C to remove insoluble GFP-polyQ aggregates.
Supernatants were then filtrated through a PVDF membrane (0.22 m) and replaced on a glass bottom 96-well plate and then subjected to FCS analysis using a ConfoCor 2 system with a water immersion objective lens (C-Apochromat 40 x 1.2 NA, Carl Zeiss) at excitation of 488 nm and emission of 505-550 nm. The confocal pinhole diameter was adjusted to 70 m and fluorescence was measured 50 times for 10 sec at room temperature. Analyses by FCS were performed as described previously (21).
Protein purification
GST-fused with Htt exon 1 (GST-Htt23Q and GST-Htt53Q) were expressed in E. coli (BL21DE3) and purified as described previously (32). Human prefoldin (hPFD) was assembled from six individual subunits of PFD that had been expressed in and purified from E. coli (BL21DE3)
as described previously (33). Proteins were visualized using an ECL Plus blotting detection system (GE Healthcare).
Filter trap assay of in vitro aggregation
Electron microscopy
Htt protein samples were diluted 10-fold with distilled water and placed on a carbon-coated copper grid and air-dried. After negative staining of samples with uranyl acetate, images were taken with an excitation voltage of 100 kV using a JEM-1011 transmission electron microscope (JEOL, Tokyo, Japan).
TIRFM single particle analysis of aggregation
A unique cysteine residue on GST-HttQ23 or and 5B 
Prefoldin prevents Htt aggregation at the small oligomer stage in vitro.
To investigate more precisely how prefoldin inhibits aggregation of pathogenic Htt, we used an in vitro aggregation assay system. First, GST-tagged prefoldin subunits were expressed in and purified from E. coli, GST was cleaved off by PreScission protease and the prefoldin complex was reconstituted as described previously (33).
GST-HttQ53 and GST-HttQ23 were expressed in and purified from E. coli, and addition of When PFD2 and PFD5 were knocked down, amounts of dimer, trimer and larger oligomers of pathogenic Htt were increased (Fig. 6F) .
Furthermore, prefoldin suppresses neuronal cell death, and dead cells did not contain Htt inclusions (Fig. 4C) . These results indicate that prefoldin inhibits elongation of large oligomers of the pathogenic Htt, thereby inhibiting subsequent aggregate and inclusion formation, and suggest that soluble large oligomers of polyQ-expanded
Htt are more toxic than are inclusions to cells.
Immunofluorescence experiments in this study
showed that prefoldin was localized in the cytosol without co-localization with inclusions in
Htt-expressing cells, in contrast to the fact that HSP70 was co-localized with inclusions (Fig. 4E ).
These results suggest that once an inclusion is formed, prefoldin is not able to disrupt inclusion formation and that the inclusion itself is not toxic C-E. Neuro-2a cells were transfected with PFD2 siRNA, PFD5 siRNA or non-specific siRNA as a control.
At 24 h after transfection, cells were transfected with expression vectors for GFP (C), GFP-polyQ (D) and Htt-GFP (E) and treated with 5 mM db-cAMP at 4 h after transfection. Aggregate-containing cells were counted at 48 h after transfection of GFP, GFP-polyQ and Htt-GFP. n=3.
F and G. Neuro-2a cells were treated as described in the legend for Figs. 2C-2E, and protein extracts prepared from cells were subjected to filter-trap assays as described in Experimental procedures. Figs. S4A and S4B ). The number of HttQ53 molecules per particle was determined by dividing fluorescence intensities of particles by that of single dye after adjusting light attenuation levels by ND filters (Supplementary Fig. 4E ). 
